A substantial advancement in glucose management is emerging with the introduction of tirzepatide at a dosage of 45mg. This new version builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, and https://bookmarkrange.com/story23230998/groundbreaking-introduction-tirzepatide-45mg-for-glucose-management